Bajetta, E <br/><br/>
Capecitabine plus oxaliplatin and irinotecan regimen every other week: a phase I/II study in first-line treatment of metastatic colorectal cancer.  [electronic resource] 

 -  Annals of oncology : official journal of the European Society for Medical Oncology  Nov 2007 
 - 1810-6 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article 
<br/><br/><label>ISSN: </label>1569-8041 
<br/><br/><label>Standard No.: </label>10.1093/annonc/mdm347  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Biopsy, Needle<br/>Camptothecin--administration & dosage<br/>Capecitabine<br/>Colorectal Neoplasms--drug therapy<br/>Confidence Intervals<br/>Deoxycytidine--administration & dosage<br/>Disease-Free Survival<br/>Dose-Response Relationship, Drug<br/>Drug Administration Schedule<br/>Female<br/>Fluorouracil--administration & dosage<br/>Follow-Up Studies<br/>Humans<br/>Immunohistochemistry<br/>Irinotecan<br/>Liver Neoplasms--drug therapy<br/>Male<br/>Maximum Tolerated Dose<br/>Neoplasm Invasiveness--pathology<br/>Neoplasm Staging<br/>Organoplatinum Compounds--administration & dosage<br/>Oxaliplatin<br/>Risk Assessment<br/>Survival Analysis<br/>Treatment Outcome